39221-60-8

Basic information

• Product Name: 2-bromo-N,N-dimethylbutyramide
• Synonyms: 2-bromo-N,N-dimethylbutyramide;2-Bromo-N,N-dimethylbutanamide
• CAS NO: 39221-60-8
• Molecular Formula: C₆H₁₂BrNO
• Molecular Weight: 194.06958
• EINECS: 254-363-7
• Mol File: 39221-60-8.mol
• Article Data: 1

Chemical Properties

• Boiling Point: 211.9°Cat760mmHg
• Flash Point: 81.9°C
• Appearance: /
• Density: 1.333g/cm³
• Vapor Pressure: 0.179mmHg at 25°C
• Refractive Index: 1.479
• PKA: -0.91±0.70(Predicted)
• CAS DataBase Reference: 2-bromo-N,N-dimethylbutyramide(CAS DataBase Reference)
• NIST Chemistry Reference: 2-bromo-N,N-dimethylbutyramide(39221-60-8)
• EPA Substance Registry System: 2-bromo-N,N-dimethylbutyramide(39221-60-8)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 39221-60-8(Hazardous Substances Data)

Usage

InChI:InChI=1/C6H12BrNO/c1-4-5(7)6(9)8(2)3/h5H,4H2,1-3H3

Upstream product

• 26074-52-2 2-bromo-butyryl bromide 
• 124-40-3 dimethyl amine 
• 80-58-0 2-Bromobutyric acid 

Downstream Products

• 59843-85-5 N,N-dimethyl-2-(4-methyl-5-phenyl-pyrazol-1-yl)-butyramide 
• 59843-84-4 N,N-dimethyl-2-(4-methyl-3-phenyl-pyrazol-1-yl)-butyramide 
• 59845-22-6 N,N-dimethyl-2-(5-methyl-3-phenyl-pyrazol-1-yl)-butyramide 
• 59844-08-5 N,N-dimethyl-2-(3-o-tolyl-pyrazol-1-yl)-butyramide 
• 59844-07-4 2-[3-(2-chloro-phenyl)-pyrazol-1-yl]-N,N-dimethyl-butyramide 
• 59844-09-6 2-[3-(2-chloro-phenyl)-4-methyl-pyrazol-1-yl]-N,N-dimethyl-butyramide 
• 59844-14-3 N,N-dimethyl-2-(4-methyl-3-o-tolyl-pyrazol-1-yl)-butyramide 

Relevant articles and documents

COMPOUNDS THAT INHIBIT MCL-1 PROTEIN

Provided herein are myeloid cell leukemia 1 protein (Mcl-1) inhibitors, methods of their preparation, related pharmaceutical compositions, and methods of using the same. For example, provided herein are compounds of Formula I, and pharmaceutically acceptable salts thereof and pharmaceutical compositions containing the compounds. The compounds and compositions provided herein may be used, for example, in the treatment of diseases or conditions, such as cancer.